The short answer is that its highly unlikely
Changes in blood sugar Because semaglutide affects glucose regulation, some patients may feel tired, lightheaded, or weak if their blood sugar fluctuates
This accidental discovery in the 1980s became the foundation for modern GLP-1 receptor agonist medications
Vincent Nacouzi as your provider, he will administer a small dose of B12 intramuscularly, typically in your arm or thigh
This does not necessarily mean GLP-1 therapy is inappropriate, but it does often mean symptoms should be monitored more closely
Using computer-aided drug design (CADD) technology, researchers designed the chemical structure of semaglutide based on the structural characteristics and binding modes of GLP-1 receptors